William Lowrance Selected Research

Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)

12/2018

Modulation of Premetastatic Niche by the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Localized High-Risk Prostate Cancer Followed by Radical Prostatectomy: A Phase II Randomized Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William Lowrance Research Topics

Disease

7	Neoplasms (Cancer) 01/2020 - 03/2009
5	Prostatic Neoplasms (Prostate Cancer) 03/2020 - 08/2017
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 08/2013
2	Neoplasm Metastasis (Metastasis) 12/2018 - 08/2017
1	Non-Muscle Invasive Bladder Neoplasms 01/2018
1	Proteinuria 02/2017
1	Chronic Renal Insufficiency 02/2017
1	Solitary Kidney 12/2015
1	Ischemia 12/2015

Drug/Important Bio-Agent (IBA)

2	Prostate-Specific Antigen (Semenogelase)IBA 01/2020 - 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	CD40 Ligand (CD40L)IBA 01/2020
1	Sunitinib (Sutent)FDA Link 01/2020
1	pazopanib FDA Link 12/2018
1	Tyrosine Kinase InhibitorsIBA 12/2018
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2018
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 12/2018

Therapy/Procedure

5	Nephrectomy 02/2017 - 03/2009
3	Prostatectomy (Retropubic Prostatectomy) 03/2020 - 08/2017
2	Therapeutics 01/2020 - 01/2018
1	Immunotherapy 01/2020
1	Adjuvant Radiotherapy 08/2017
1	Radiotherapy 08/2017
1	Aftercare (After-Treatment) 02/2017
1	Lymph Node Excision (Lymph Node Dissection) 06/2015
1	Adrenalectomy 06/2015